A new analysis of existing studies suggests that people taking dopamine agonists for pituitary adenomas may be more likely to develop impulse-control disorders, such as compulsive gambling, shopping, or eating. The analysis combined data from several observational studies, which means it can show a link but cannot prove that the medications cause these behaviors.
The researchers looked at 1,247 patients with pituitary adenomas. They found that those who took dopamine agonists had more than twice the odds of having an impulse-control disorder compared to those who did not take these drugs. The results were consistent across the studies, with no signs of variation.
This finding is important because dopamine agonists are commonly used to treat pituitary tumors that produce too much prolactin. While these drugs are effective, patients and doctors should be aware of the potential for impulse-control issues. The analysis did not report on side effects or how well patients tolerated the treatment.
Because this is a meta-analysis of observational data, it cannot establish cause and effect. More research is needed to confirm the link and understand who might be at higher risk. If you are taking a dopamine agonist and notice changes in your behavior, talk to your doctor.
